Penn Capital Management’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CNMD
CB
Penn Capital Management's CNMD Position: Q1 2026 in Review
Penn Capital Management sold out of CONMED (CNMD) in Q1 2026, closing a stake of 51,493 shares — an estimated $2.09M sold.
Penn Capital Management first reported a position in CNMD in Q2 2020 and held it in 14 quarters. The position peaked at $15.3M in Q1 2022. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.
- Penn Capital Management reported no remaining CONMED position as of Q1 2026 after selling out during the quarter.
- Penn Capital Management sold 51,493 CONMED shares in Q1 2026, an estimated $2.09M.
- Penn Capital Management first reported a position in CONMED in Q2 2020 and held it in 14 quarters.
- Penn Capital Management's CONMED position peaked at $15.3M in Q1 2022.
- 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.
Based on Penn Capital Management's 13F filing for Q1 2026, filed 7 May 2026.